These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36566436)
61. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA). Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882 [TBL] [Abstract][Full Text] [Related]
62. Per- and polyfluoroalkyl substances (PFASs) in Swedish household dust and exposure of pet cats. Weiss JM; Jones B; Koekkoek J; Bignert A; Lamoree MH Environ Sci Pollut Res Int; 2021 Aug; 28(29):39001-39013. PubMed ID: 33745045 [TBL] [Abstract][Full Text] [Related]
63. Association between serum levels of TSH and free T4 and per- and polyfluoroalkyl compounds concentrations in pregnant women. Li A; Hou J; Fu J; Wang Y; Hu Y; Zhuang T; Li M; Song M; Jiang G J Environ Sci (China); 2023 Feb; 124():11-18. PubMed ID: 36182121 [TBL] [Abstract][Full Text] [Related]
65. In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites. Zhang J; Kamstra JH; Ghorbanzadeh M; Weiss JM; Hamers T; Andersson PL Environ Sci Technol; 2015 Aug; 49(16):10099-107. PubMed ID: 26207645 [TBL] [Abstract][Full Text] [Related]
67. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach. Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629 [TBL] [Abstract][Full Text] [Related]
68. Recombinant transthyretin purification and competitive binding with organohalogen compounds in two gull species (Larus argentatus and Larus hyperboreus). Ucán-Marín F; Arukwe A; Mortensen A; Gabrielsen GW; Fox GA; Letcher RJ Toxicol Sci; 2009 Feb; 107(2):440-50. PubMed ID: 19033396 [TBL] [Abstract][Full Text] [Related]
69. Crystal structures of human transthyretin complexed with glabridin. Yokoyama T; Kosaka Y; Mizuguchi M J Med Chem; 2014 Feb; 57(3):1090-6. PubMed ID: 24422526 [TBL] [Abstract][Full Text] [Related]
70. Identification of Transthyretin Fibril Formation Inhibitors Using Structure-Based Virtual Screening. Ortore G; Martinelli A ChemMedChem; 2017 Aug; 12(16):1327-1334. PubMed ID: 28422428 [TBL] [Abstract][Full Text] [Related]
71. Structure-Directed Screening and Analysis of Thyroid-Disrupting Chemicals Targeting Transthyretin Based on Molecular Recognition and Chromatographic Separation. Huang K; Wang X; Zhang H; Zeng L; Zhang X; Wang B; Zhou Y; Jing T Environ Sci Technol; 2020 May; 54(9):5437-5445. PubMed ID: 32252528 [TBL] [Abstract][Full Text] [Related]
72. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding. Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966 [TBL] [Abstract][Full Text] [Related]
73. Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Almeida MR; Gales L; Damas AM; Cardoso I; Saraiva MJ Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):587-96. PubMed ID: 16266291 [TBL] [Abstract][Full Text] [Related]
75. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation. Huang G; Ueda M; Tasaki M; Yamashita T; Misumi Y; Masuda T; Suenaga G; Inoue Y; Kinoshita Y; Matsumoto S; Mizukami M; Tsuda Y; Nomura T; Obayashi K; Ando Y Amyloid; 2017 Mar; 24(1):24-29. PubMed ID: 28081656 [TBL] [Abstract][Full Text] [Related]
76. Directional thyroid hormone distribution via the blood stream to target sites. Janssen ST; Janssen OE Mol Cell Endocrinol; 2017 Dec; 458():16-21. PubMed ID: 28257828 [TBL] [Abstract][Full Text] [Related]
77. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492 [TBL] [Abstract][Full Text] [Related]
78. The affinity of transthyretin for T Richardson SJ; Van Herck S; Delbaere J; McAllan BM; Darras VM Gen Comp Endocrinol; 2018 Aug; 264():131-137. PubMed ID: 28919452 [TBL] [Abstract][Full Text] [Related]
79. The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition. Trivella DB; Sairre MI; Foguel D; Lima LM; Polikarpov I J Struct Biol; 2011 Feb; 173(2):323-32. PubMed ID: 20937391 [TBL] [Abstract][Full Text] [Related]
80. Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Ren XM; Guo LH Environ Sci Technol; 2012 Apr; 46(8):4633-40. PubMed ID: 22482873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]